Literature DB >> 8102180

Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis.

B Poeggeler1, R J Reiter, D X Tan, L D Chen, L C Manchester.   

Abstract

Melatonin is a very potent and efficient endogenous radical scavenger. The pineal indolamine reacts with the highly toxic hydroxyl radical and provides on-site protection against oxidative damage to biomolecules within every cellular compartment. Melatonin acts as a primary non-enzymatic antioxidative defense against the devastating actions of the extremely reactive hydroxyl radical. Melatonin and structurally related tryptophan metabolites are evolutionary conservative molecules principally involved in the prevention of oxidative stress in organisms as different as algae and rats. The rate of aging and the time of onset of age-related diseases in rodents can be retarded by the administration of melatonin or treatments that preserve the endogenous rhythm of melatonin formation. The release of excitatory amino acids such as glutamate enhances endogenous hydroxyl radical formation. The activation of central excitatory amino acid receptors suppress melatonin synthesis and is therefore accompanied by a reduced detoxification rate of hydroxyl radicals. Aged animals and humans are melatonin-deficient and more sensitive to oxidative stress. Experiments investigating the effects of endogenous excitatory amino acid antagonists and stimulants of melatonin biosynthesis such as magnesium may finally lead to novel therapeutic approaches for the prevention of degeneration and dysdifferentiation associated with diseases related to premature aging.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102180     DOI: 10.1111/j.1600-079x.1993.tb00498.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  83 in total

Review 1.  The circadian control of skin and cutaneous photodamage.

Authors:  Joshua A Desotelle; Melissa J Wilking; Nihal Ahmad
Journal:  Photochem Photobiol       Date:  2012-02-21       Impact factor: 3.421

Review 2.  Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.

Authors:  Neeraj Joshi; Joyshree Biswas; C Nath; Sarika Singh
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

Review 3.  Melatonin: an inhibitor of breast cancer.

Authors:  Steven M Hill; Victoria P Belancio; Robert T Dauchy; Shulin Xiang; Samantha Brimer; Lulu Mao; Adam Hauch; Peter W Lundberg; Whitney Summers; Lin Yuan; Tripp Frasch; David E Blask
Journal:  Endocr Relat Cancer       Date:  2015-04-15       Impact factor: 5.678

Review 4.  Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis.

Authors:  Darío Acuña-Castroviejo; Germaine Escames; Luis C López; Ana B Hitos; Josefa León
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 5.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 6.  Skin, reactive oxygen species, and circadian clocks.

Authors:  Mary A Ndiaye; Minakshi Nihal; Gary S Wood; Nihal Ahmad
Journal:  Antioxid Redox Signal       Date:  2013-11-21       Impact factor: 8.401

Review 7.  Influence of melatonin and photoperiod on animal and human reproduction.

Authors:  A Cagnacci; A Volpe
Journal:  J Endocrinol Invest       Date:  1996-06       Impact factor: 4.256

Review 8.  Determinants of health and disease.

Authors:  S Wolf
Journal:  Integr Physiol Behav Sci       Date:  1996 Jan-Mar

Review 9.  Bench to cribside: the path for developing a neuroprotectant.

Authors:  Nelina Ramanantsoa; Bobbi Fleiss; Myriam Bouslama; Boris Matrot; Leslie Schwendimann; Charles Cohen-Salmon; Pierre Gressens; Jorge Gallego
Journal:  Transl Stroke Res       Date:  2012-12-21       Impact factor: 6.829

10.  Effects of melatonin in reducing the toxic effects of doxorubicin.

Authors:  Eser Oz; Mustafa N Ilhan
Journal:  Mol Cell Biochem       Date:  2006-04-20       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.